The median U.S. salary for Psychiatrist roles is $250K, and the employment outlook is much faster than average (2026).
The question psychiatrists most consistently fumble is, “Tell me about a time you changed course after realizing your formulation or treatment plan was wrong.” It filters out otherwise qualified candidates because interviewers are testing whether you can own diagnostic uncertainty, medication risk, and patient harm without becoming defensive or vague. In 2026, psychiatrist interviews usually combine a recruiter screen, a physician-leader interview, case-based clinical assessment, and meetings with nursing, therapy, and operations partners. Academic and hospital roles often add a panel and documentation or consult-liaison case discussion; outpatient groups may focus heavily on panel management, prescribing boundaries, and telepsychiatry workflow. The deciding factor is rarely board certification alone. It is whether you can make safe, defensible decisions, communicate them clearly, and function as the accountable physician in a multidisciplinary system.
How to answer: Use a case in which new collateral, longitudinal history, toxicology, or a medication response materially changed your formulation. State the original working diagnosis, the signal you missed, your immediate safety actions, how you informed the patient and team, and the outcome; do not disguise a routine titration as an error.
Why they ask: The interviewer is assessing diagnostic humility, patient-safety judgment, and whether you document and repair errors rather than rationalize them. Psychiatry carries particular risk when an early formulation drives the wrong medication or level-of-care decision.
Example answer
“I treated a 29-year-old outpatient initially as having treatment-resistant major depression and increased sertraline after a brief intake. At the follow-up, her partner described prior four-day periods of no sleep, impulsive spending, and unusually goal-directed behavior, and I recognized that I had underweighted the bipolar-spectrum history. I stopped the antidepressant escalation, completed a structured bipolar assessment, started lamotrigine with clear rash counseling, and arranged weekly follow-up while obtaining prior records. I told the patient directly that my initial formulation had been incomplete and documented the revised risk and treatment rationale. Over the next 12 weeks, her PHQ-9 fell from 21 to 8 without hypomanic symptoms, and I changed my intake template to require documented screening for lifetime hypomania before antidepressant monotherapy.”
How to answer: Choose a real disagreement involving risk, diagnosis, medication, or disposition rather than a personality clash. Explain each discipline's concern, the clinical evidence you reviewed, the shared plan you created, and how you prevented the conflict from fragmenting care.
Why they ask: They want to know whether you can lead without treating multidisciplinary disagreement as insubordination. Strong psychiatrists protect the patient while integrating observations from people who may see behavior, adherence, and safety risks that the prescriber does not.
Example answer
“On an inpatient unit, the social worker strongly opposed discharge for a patient with schizophrenia because he had missed two prior housing appointments, while I believed his acute psychosis had resolved and prolonged hospitalization would not solve the housing barrier. I asked for a same-day huddle with nursing, social work, and the patient, then reviewed his violence-risk history, current MSE, LAI adherence plan, and the housing program's actual criteria. We agreed to delay discharge 24 hours to administer his paliperidone injection, confirm transportation, and complete a warm handoff to the ACT team rather than discharge with only written instructions. I documented the differing views and the specific protective factors and residual risks. He attended the intake appointment the next day and had no psychiatric readmission in the following 90 days.”
How to answer: Describe the adverse effect or communication failure precisely, including monitoring data and severity. Show how you assessed urgency, altered the regimen, disclosed what happened, reported or documented the event when appropriate, and redesigned the process that allowed it.
Why they ask: The interviewer is probing whether you handle prescribing consequences with transparency, clinical rigor, and appropriate escalation. A psychiatrist who blames the pharmacy, resident, or patient is a liability.
Example answer
“A patient I started on olanzapine for severe bipolar mania developed rapid weight gain and a fasting glucose increase from 96 to 128 within six weeks. Although the medication was clinically effective, I recognized that I had not made the metabolic-monitoring timeline explicit enough in my after-visit plan or coordinated early nutrition support. I called the patient, acknowledged that we had not anticipated the burden adequately, reviewed alternatives, and cross-tapered to lurasidone while involving her PCP for glucose follow-up. I entered a medication-safety note and worked with our clinic staff to create an EHR order set that auto-generated baseline and 12-week A1c, lipids, weight, and waist-circumference reminders. The patient returned to baseline glucose within four months, and our team's documented 12-week metabolic monitoring increased from 62% to 91% over the next quarter.”
How to answer: Use a case where a structural barrier threatened safety or continuity, such as an inappropriate denial, inaccessible follow-up, language barrier, or discriminatory framing of symptoms. Explain the clinical facts you marshaled, the stakeholders you engaged, and the measurable access or safety result.
Why they ask: This tests whether you can convert advocacy into clinically credible action across utilization review, emergency medicine, insurers, schools, or community agencies. Interviewers want evidence that you can defend necessary care without indiscriminately demanding admission or medication.
Example answer
“In consultation-liaison psychiatry, I evaluated a Spanish-speaking patient with severe postpartum depression, intrusive harm thoughts, and escalating suicidal ideation who was being considered for routine outpatient referral because she denied intent during a brief ED reassessment. I used a certified interpreter, obtained collateral from her spouse, completed a detailed suicide assessment, and explained to utilization review why the combination of symptom severity, sleep deprivation, limited support, and inability to safety-plan made discharge unsafe. I coordinated voluntary admission and ensured that lactation considerations were addressed rather than used as a reason to avoid treatment. Before discharge, I arranged a bilingual perinatal program appointment within seven days and documented a medication plan compatible with breastfeeding. She attended both the first psychiatric and therapy visits, and her EPDS decreased from 24 to 9 over eight weeks.”
How to answer: Walk through lifetime episodicity, decreased need for sleep versus insomnia, increased energy, behavior change, family history, age at onset, antidepressant activation, substance use, and collateral. Name practical tools such as the MDQ or CIDI screen, but make clear that they support rather than replace a clinical interview and records review.
Why they ask: The interviewer is testing whether your diagnostic process prevents antidepressant-induced activation, missed bipolar disorder, and superficial checklist medicine. They want a longitudinal formulation, not a single screening score.
Example answer
“I start by separating current depressive symptoms from the patient's lifetime mood course. I ask for concrete examples of periods with decreased need for sleep, increased goal-directed activity, irritability, spending, sexual risk-taking, and observable change from baseline, then obtain collateral whenever possible. I review prior records for emergency visits, antidepressant activation, and episodes that occurred outside substance use, and I assess family history of bipolar disorder. A positive MDQ prompts deeper questioning; it does not establish the diagnosis by itself. If bipolarity remains plausible, I avoid reflexive antidepressant monotherapy and discuss mood-stabilizing options, monitoring, and the uncertainty openly with the patient.”
How to answer: Build a plan around prior response, adverse effects, insight, injection feasibility, housing and transportation, substance use, capacity, and patient goals. Include LAI discussion, AIMS and metabolic monitoring, clozapine criteria when relevant, and coordination with primary care and case management.
Why they ask: This assesses whether you can balance relapse prevention, adverse-effect monitoring, shared decision-making, and practical adherence barriers. A strong answer addresses more than choosing an antipsychotic.
Example answer
“I first identify why doses are missed: sedation, paranoia about medication, cost, disorganization, or inability to get to a pharmacy require different interventions. For a patient with recurrent relapse after oral risperidone but significant weight gain, I would review an LAI option such as aripiprazole with the patient and explain expected benefits, akathisia risk, and injection logistics in plain language. I obtain baseline weight, blood pressure, A1c, lipids, and AIMS, then schedule the next monitoring points before the patient leaves. If two adequate antipsychotic trials have failed, I evaluate for clozapine rather than cycling indefinitely through similar agents, while being explicit about ANC monitoring. I involve the PCP and case manager so medication access, metabolic care, and missed-injection outreach are one coordinated plan.”
How to answer: Describe brief, targeted interventions tied to a formulation and measurement-based goals: behavioral activation, exposure planning, sleep regularity, cognitive reframing, or panic psychoeducation. Explain how you coordinate with a therapist, document the intervention, and use instruments such as PHQ-9, GAD-7, or Y-BOCS to evaluate response.
Why they ask: The interviewer wants to see that you understand the boundary between focused psychiatric interventions and a full psychotherapy course. They are assessing whether you can use CBT-informed care without claiming expertise you are not delivering or duplicating the therapist's work.
Example answer
“In a 25-minute medication visit for panic disorder, I do not attempt to replace weekly CBT, but I can reinforce its mechanisms. For example, with a patient avoiding grocery stores, I review the panic cycle, identify the safety behavior of leaving immediately, and agree on one graded exposure before the next visit. I coordinate with the therapist so we are using the same exposure hierarchy rather than giving competing advice. We track panic frequency and GAD-7 scores alongside medication effects, including whether a benzodiazepine is undermining exposure learning. If avoidance remains severe despite adequate CBT engagement and an SSRI trial, I revisit diagnosis, adherence, comorbidity, and the intensity of treatment needed.”
How to answer: State the safety workflow: confirm patient identity, physical location, callback number, emergency contact, local EMS jurisdiction, privacy, and a contingency plan at the start. Then describe a full risk assessment, means-safety discussion, documentation, and when video limitations, intoxication, or escalating risk require emergency evaluation or a higher level of care.
Why they ask: They are evaluating whether you understand that telepsychiatry changes emergency response, privacy verification, observation, and licensure requirements. “I ask about SI like I do in person” is not an adequate answer.
Example answer
“At the beginning of every telepsychiatry intake, I verify the patient's identity, exact location, callback number, emergency contact, and whether they have a private space to speak. If suicidality emerges, I assess ideation, intent, plan, access to means, prior attempts, intoxication, agitation, protective factors, and the reliability of the virtual interaction rather than relying on a safety contract. For a patient with escalating intent and access to a firearm, I keep them engaged on video while staff contact the listed support person and local emergency services in the patient's jurisdiction. I document the location verification, risk formulation, consultation, and disposition rationale in the EHR. For lower acute risk, I create a collaborative written safety plan, confirm lethal-means reduction, and arrange a specific follow-up interval rather than saying “call if worse.””
How to answer: Explain that you would keep the patient engaged, establish location and immediate access to the firearm, assess imminence and capacity, and mobilize emergency support. Address voluntary hospitalization first when feasible, but state clearly when emergency petitioning, mobile crisis, law enforcement, or EMS is necessary under applicable state law.
Why they ask: This is a direct test of acute suicide-risk management, legal and ethical judgment, and ability to act decisively while preserving dignity. The interviewer is listening for a risk formulation and disposition process, not a recitation of a screening tool.
Example answer
“I would treat that as potentially imminent risk and would not end the encounter with a verbal promise to stay safe. I would confirm the patient's exact location, whether the gun is present or accessible, whether they are alone or intoxicated, and whether a trusted person can immediately secure the weapon. I would ask them to accept voluntary ED evaluation while I contact the receiving facility or mobile crisis team and, if they refuse despite credible imminent danger, initiate the emergency process permitted in that state. I would remain engaged by phone or video when safe until the handoff occurs and communicate the specific risk factors to the receiving clinician. My documentation would include the patient's statements, firearm access, collateral efforts, protective factors, legal basis for the disposition, and all handoff details.”
How to answer: Anchor the answer in attention, fluctuating course, baseline cognition, vital signs, medication exposure, substance withdrawal, infection, metabolic abnormalities, and collateral. Explain that psychiatric symptoms do not exclude delirium and that you would articulate what medical evaluation or observation remains necessary.
Why they ask: The interviewer is testing whether you can resist premature psychiatric labeling of delirium and manage interprofessional pressure. Missing a medical cause of altered mental status is a high-stakes psychiatric consultation failure.
Example answer
“I would state that disorientation and fluctuating attention make delirium a leading concern until proven otherwise, regardless of the negative CT. I would perform or request a focused attention assessment, review vitals, oxygenation, glucose, medication and anticholinergic burden, withdrawal risk, labs, urinalysis when indicated, and collateral on baseline cognition. I would tell the ED physician that I cannot support psychiatric clearance for discharge if the patient cannot reliably participate in a safety assessment because of altered attention or cognition. If severe agitation requires medication, I would recommend the least restrictive approach and choose agents with attention to QTc, EPS risk, and the suspected etiology. Once medical causes are addressed or stabilized, I would reassess for a primary psychiatric syndrome and document the distinction clearly.”
How to answer: Describe a consistent controlled-substance policy: review the PDMP, prior agreement, urine drug screening when clinically indicated, attendance history, comorbid substance use, and functional benefit. Distinguish a limited bridge with rapid reassessment from an automatic refill, and explain how you document the rationale and offer alternative care pathways.
Why they ask: This probes prescribing boundaries, diversion risk, continuity of care, and whether you can avoid both abandonment and unsafe convenience prescribing. It is especially relevant in high-volume outpatient and telepsychiatry settings.
Example answer
“I would not automatically refill a controlled substance solely because the patient reports stability, but I also would not treat missed visits as proof of misuse. I would review the PDMP, the last fill date, the treatment agreement, prior toxicology if applicable, documented functional benefit, and any warning signs such as early requests or multiple prescribers. If there is no concerning pattern and abrupt discontinuation would create a foreseeable clinical risk, I may provide a short bridge supply tied to a scheduled evaluation within days, not weeks. If the review identifies diversion or unsafe co-prescribing, I would explain the concern directly, avoid an unsafe refill, and offer appropriate substance-use or urgent psychiatric assessment. I would document the objective data, patient communication, and plan so the decision is clinically defensible rather than operationally driven.”
How to answer: Explain how you assess decision-making capacity for the specific choices at hand, immediate danger, grave disability, psychosis, and ability to use supports. Offer voluntary options and concrete harm-reduction steps, obtain collateral with consent when possible, intensify monitoring, and reassess as the clinical picture evolves.
Why they ask: They are assessing capacity analysis, respect for autonomy, practical harm reduction, and knowledge of the threshold for involuntary treatment. Strong psychiatrists do not equate a manic diagnosis with automatic incapacity or wait passively for a catastrophe.
Example answer
“I would first assess whether the patient can understand and appreciate the consequences of refusing treatment and of their financial behavior, rather than assuming incapacity because they are manic. I would evaluate sleep loss, psychosis, substance use, access to funds, dependents, threats, housing, and whether family or a trusted support can help monitor deterioration. If they retain capacity and do not meet involuntary criteria, I would offer urgent voluntary treatment, simplify the medication discussion, arrange very close follow-up, and develop specific financial harm-reduction steps such as pausing credit cards or involving a chosen support person. With permission, I would obtain collateral and give supports clear instructions about behavioral thresholds that require crisis evaluation. I would document the capacity analysis and legal criteria carefully, because worsening mania can change both within hours or days.”
Interviewers will also have your resume in front of them — make sure it holds up. See our psychiatrist resume example with salary data and proven bullet points.
Expect at least one case, and often several embedded in conversation. Hospital and consult-liaison roles commonly test delirium, agitation, capacity, suicide risk, and disposition; outpatient roles lean toward diagnosis, medication management, controlled substances, and panel workflow. Answer in a structured sequence: formulation, missing data, immediate safety issues, treatment options, and follow-up. Do not jump directly to a drug and dose before establishing the diagnosis and level of risk.
Do not give one number without separating base salary from call pay, productivity, signing bonus, loan repayment, benefits, and malpractice coverage. A direct answer is: “Given the scope, call expectations, patient mix, and whether compensation includes RVU or quality incentives, I am targeting a total package in the appropriate part of the $128,430 to $400,000 market range; I would like to understand the base, productivity threshold, and realistic first-year earnings.” For an employed general psychiatry role, anchor your target to local demand and workload, not the national median of $249,760 alone. Ask whether the quoted range reflects actual physician earnings or a theoretical productivity maximum.
Yes. They may not expect you to conduct a 45-minute CBT session, but they will expect you to recognize when CBT, DBT, exposure therapy, family therapy, or substance-use treatment is clinically indicated. Explain the brief evidence-based interventions you use in medication visits and how you coordinate with therapists. Avoid claiming that supportive counseling during a refill visit is equivalent to a structured psychotherapy modality.
State the facts briefly, your role, the clinical lessons, and what changed in your practice. Do not minimize a serious event, blame the patient, or disclose protected details that are not necessary to answer the question. For a difficult outcome without a formal claim, focus on the risk formulation, consultation, documentation, and system improvement that followed. Psychiatric leaders are more concerned by evasiveness than by a thoughtfully handled adverse event.
Ask questions that expose the clinical operating model: “What is the expected psychiatrist panel, new-evaluation length, and protected time for collateral, prior authorization, and care coordination?” Ask how the organization manages ED boarding, post-discharge follow-up, involuntary-treatment decisions, clozapine infrastructure, and after-hours coverage. Also ask which quality metrics are reviewed at the physician level and whether they measure access, readmissions, metabolic monitoring, or symptom outcomes. These questions signal that you understand psychiatric quality depends on the system around the prescription pad.
Paste a real job description and our free AI generator predicts the 5 questions you're most likely to face — tailored to that exact posting.
Try the free generatorAnswer in a live voice conversation with an AI interviewer that listens, follows up, and gives instant feedback. Free to start.
Start practicing